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ABSTRACT 
In the period 1985-1988, 62 focal liver lesions in 58 
cirrhotic patients were studied by ultrasonography; 12 
of these focal lesions were documented to be regener- 
ating lesions by echo-guided fine-needle biopsy. During 
an average follow-up period of 10.2 months (range 3-22 
months), hepatocellular carcinoma was subsequently 
found in 10 of the cases of regenerating nodules, 
whereas the initial diagnosis of regenerating nodule 
was confirmed in the remaining two cases. Based upon 
this finding, it is suggested that every focal maim 
Visualized by ultrasonography in a cirrhotic liver 
should either considered to be a neoplastic lesion or at 
least a preneoplastic lesion if the possibility of either a 
metastatic or benign lesion (eg hemangiomas, focal 
fatty liver change areas) can be excluded. Therefore 
either he-needle aspiration or biopsy of all ultrasono- 
graphically revealed mass lesions within a cirrhotic 
liver is advised, such that early appropriate treatment 
for hepatocellular carcinoma can be instituted. 
COMMENTS 
This study attempts to address an important issue. 
What is the malignant potential of regenerative nodules 
in patients with cirrhosis? The authors identified 12 
focal liver lesions that they termed “regenerative nod- 
ules” because they were histologically benign on initial 
evaluation. With mean follow-up of 10 mo, 10 of 12 
(83%) of the regenerative nodules were demonstrated to 
be HCC. The authors discuss the two obvious options: 
(a) these were premalignant lesions that degenerated 
and became truly malignant; or (b) these were misdiag- 
nosed initially and were malignant all the time. 
It is essential to distinguish between regenerative 
nodules and focal lesions in a cirrhotic liver. Most 
patients with regeneration alone do not have focal 
lesions. Typically, regenerative nodules in patients with 
cirrhosis are recognized by irregularities of the liver 
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surface because they are isoechoic with the surrounding 
tissue and are not directly visible by ultrasound (1). If 
lesions are hypoechoic (as was the case for most of the 
lesions studied) or of mixed echogenicity, they are more 
likely to be malignant. 
The authors identified 62 focal lesions from the 
ultrasonographs of 502 patients with histologically 
diagnosed cirrhosis. Less than 12.5% in this study had 
focal lesions, yet by definition all patients with cirrhosis 
have “fibrosis. . . with regenerative nodules” (2). The 
prevalence of malignancy in these focal lesions is very 
high because 89% were either initially or subsequently 
proven to be cancer. We are not given information about 
the prevalence of HCC in the other 87.5% of patients 
without focal lesions. This is important information, 
however, because if the prevalence in this group of 
patients was low, the overall incidence of 12.5% would be 
close to that expected in patients with cirrhosis. Thus 
ultrasound may simply be detecting those patients with 
HCC as evidenced by a focal lesion. 
Inherent problems can be seen with all tests used in 
the evaluation of focal mass lesions. Tissue obtained by 
fine-needle aspirate (FNA) is not always adequate to 
distinguish well-differentiated HCC from benign hepa- 
tocytes. An ultrasound-guided liver biopsy procedure in 
which the hepatic architecture is preserved is more able 
to easily distinguish well-differentiated tumors from 
normal hepatocytes, but it is also subject to sampling 
error. 
A recent study published in HEPATOLOGY (3) identified 
160 nodular lesions by ultrasound and investigated 
them with a thin-needle biopsy procedure. The majority 
(82%) were malignant at initial evaluation. To rule out 
sampling error, benign lesions had biopsy procedures 
again within a few days. The 17 cases of benign 
regenerative nodules were observed for a year. No 
enlargement was demonstrated by ultrasound, and no 
lesion became malignant. Indeed, four of the lesions 
became undetectable by ultrasound. The authors con- 
cluded that large regenerative nodules are not prema- 
lignant lesions. Why do these apparently similar studies 
differ so radically in their conclusions? Possibilities 
include: (a) The initial evaluation to rule out malignancy 
was more rigorous in the second study. A biopsy rather 
than FNA was performed, and benign lesions were 
confirmed by repeat biopsy. (b) Considerable heteroge- 
neity in the ultrasound patterns existed in the first study 
(which should raise the index of suspicion for malig- 
nancy), whereas all lesions in the second study were 
hypoechoic. (c> Most lesions in the second study were 
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undetectable by computed tomography (CT) scan. We 
are not given this information in the first study, but 
benign regenerative nodules are typically not visible by 
CT. If a focal lesion is confirmed by CT scan, again the 
question of malignancy should be raised. (d) Most lesions 
in the first study but not the second study enlarged with 
follow-up, which should also suggest HCC. 
So what should we do with the asymptomatic patient 
with known cirrhosis and a focal lesion demonstrated by 
ultrasound? Most are going to have HCC. If the 
a-fetoprotein (AFP) level is high (> 1,000 ng/ml), the 
patient almost certainly has HCC, and histological 
confirmation may not be necessary. A low AFP does not 
rule out malignancy. Although CT scan is not feasible for 
screening programs in the Far East, in the United States 
most ultrasound lesions will be confirmed by CT before 
obtaining the histological study. Ultrasound-guided, 
FNA should then be performed and, if histologically 
benign, repeated with a thin liver-biopsy needle. If the 
diagnosis of HCC is not made, the prudent course is to 
observe the patient. A rising AFP level and/or sono- 
graphic enlargement of the lesion should prompt further 
invasive evaluation by either an ultrasound-guided or 
laparoscopic biopsy procedure. 
Are regenerative nodules premalignant lesions? The 
cirrhotic liver per se is associated with an increased risk 
of HCC, the risk varying with the cause of the liver 
disease. However, regenerative nodule is not synon- 
ymous with focal liver lesion. Every focal mass lesion in 
a cirrhotic liver should simply be considered malignant 
until proven otherwise (e.g., with a follow-up of more 
than 2 yr without observed progression). With careful 
evaluation, most will be shown to be malignant initially. 
The evidence that large regenerative nodules have 
greater malignant potential than the surrounding cir- 
rhotic liver is slim at best. 
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LIVER TRANSPLANTATION RESTORES FEMALE 
REPRODUCTIVE ENDOCRINE FUNCTION 
Cundy TF, O'Grady JG, Williams R. Recovery of 
menstruation and pregnancy after liver transplantation. 
Gut 1990;31:337-338. 
ABSTRACT 
The effect of successful liver transplantation on 
menstrual function was assessed by questionnaire in 44 
women transplanted for various types of end stage liver 
disease, acute liver failure or malignant disease. Sig- 
nificant amenorrhoea ( >one year) was present in 48% 
of women with chronic liver disease before transplan- 
tation, and was reversed within 10 months of surgeryin 
all but one of the pre-menopausal patients who had 
primary amenorrhoea and hypogonadotrophic hypo- 
gonadism. Two patients became pregnant five months 
and 1-5 years after transplantation, but in one instance 
the pregnancy waa umuccessful, possibly as a conse- 
quence of cyclosporin related intrauterine growth 
retardation. 
Scantlebury V, Gordon R, Tzakis A, Koneru B, Bow- 
man J, Mazzaferro V, Stevenson WC, et al. Childbearing 
after liver transplantation. Transplantation 1990;49: 
ABSTRACT 
Seventeen female patients who underwent ortho- 
topic liver transplantation between June 1973 and 
June 1987 became pregnant 5 months to 11 years 
after transplantation. Immunosuppression was main- 
tained with combinations of prednisone, cycloeporine, 
and azathioprine prior to and during pregnancy. 
One patient discontinued immunosuppression after 
knowledge of pregnancy, taking only azathioprine 
sporadically. Mean age at time of delivery was 26 years. 
Twelve patients had no alteration in liver function 
studies; 7 patients demonstrated mild or moderate 
enzyme elevations prior to delivery, with one case of 
rejection confirmed by percutaneous liver biopsy. 
Mdor problems related to pregnancy were hyper- 
tension, anemia, and hyperbilirubinemia. Twenty live 
births occurred (2 patients had 2 separate pregnancies, 
one patient has a set of twins); 13 were by caesarian 
section, 7 by vaginal delivery. Eleven of the 13 cae- 
sarian births were premature by gestational age. All 
vaginal births were term. Toxemia of pregnancy and 
early rupture of membranes were the principal indi- 
cations for caesarean section. 
There were no congenital abnormalities or birth 
defects and all the children are surviving well. Fif- 
teen of 16 children older than one year have normal 
physical and mental development, with one child 
manifesting immature speech development. Four 
children are under one year, all with normal mile- 
stones thus far. Sixteen of the 17 mothers are alive 
from 2-18 years after transplantation; the only death 
was from a lymphoma, almost 4 years after transplan- 
tation and 2% years after delivery. This experience 
suggests that women undergoing liver transplantation 
can safely bear children despite an increased risk of 
premature caesarian births. The effect of chronic 
immunosuppression of female pediatric patients on 
their reproductive potential later in adulthood re- 
mains to be fully evaluated but the results so fa r  are 
favorable. 
COMMENTS 
In the past 20 yr, liver transplantation has emerged as 
the treatment of choice for many symptomatic patients 
317-321. 
